Aster DM Healthcare Share Price Target Forecast 2022, 2023, 2025, 2030

Note:- If You Are Invested In The Stock And Still Got The Queries You Can Ask Here In Stock Market Traders & Investors QNA Forum. We Will Help You Clear Your Doubts. Happy Investing !!


4 January, 2022

ICICI Direct offers Aster DM Healthcare at a target price of Rs 250.

Aster DM Healthcare gets a buy call from ICICI Direct with a target price of Rs 250. Aster DM Healthcare is now trading at Rs 178.75 on the market. When the price of Aster DM Healthcare Ltd. reaches the specified objective, the analyst estimates it will take one year.

Aster DM Healthcare Ltd., founded in 2008, is a Mid Worth business in the Hospitals & Allied Services category with a market cap of Rs 8926.30 crore.

For the fiscal year ending 31-Mar-2021, Aster DM Healthcare Ltd.’s primary products/revenue segments include Hospital Services, Other Operating Revenue, Pharmaceuticals, Other Services, and Consultancy Income.

Financials

The firm reported a Consolidated Total Income of Rs 2513.45 Crore for the quarter ended September 30, 2021, up 5.62 percent from the previous quarter’s Total Income of Rs 2379.63 Crore and up 10.45 percent from the same quarter last year’s Total Income of Rs 2275.65 Crore. In the most recent quarter, the company generated a net profit after tax of Rs 126.60 crore.

Reasons for Investing

Aster is now trying to extend its network in India using an asset light approach, but it is still on solid ground because to FCF generated by GCC. From FY22E onwards, the brokerage expects progressive margin and RoCE improvement in Aster’s integrated business model, driven by greater occupancy and capacity optimization in new assets. It keeps its buy recommendation and values Aster DM at Rs 250 SOTP.

FII Holdings/Promoter

As of September 30, 2021, promoters controlled 37.88 percent of the firm, FIIs 10.8%, and DIIs 8.47 percent.

economictimes.com is the source for this information.


28 December, 2021

ICICI Securities recommends Aster DM Healthcare with a target price of Rs 226.

Aster DM Healthcare got a buy call from ICICI Securities with a target price of Rs 226. Aster DM Healthcare is currently selling for Rs 175.

When the price of Aster DM Healthcare Ltd. reaches the specified objective, the analyst estimates it will take one year.
Aster DM Healthcare Ltd., founded in 2008, is a Mid Worth business in the Hospitals & Allied Services category with a market cap of Rs 8728.99 Crore.

For the fiscal year ending 31-Mar-2021, Aster DM Healthcare Ltd.’s primary products/revenue segments include Hospital Services, Other Operating Revenue, Pharmaceuticals, Other Services, and Consultancy Income.

Financials

The firm reported a Consolidated Total Income of Rs 2513.45 Crore for the quarter ended September 30, 2021, up 5.62 percent from the previous quarter’s Total Income of Rs 2379.63 Crore and up 10.45 percent from the same quarter last year’s Total Income of Rs 2275.65 Crore. In the most recent quarter, the company generated a net profit after tax of Rs 126.60 crore.

FII Holdings/Promoter

As of September 30, 2021, promoters controlled 37.88 percent of the firm, FIIs 10.8%, and DIIs 8.47 percent.

economictimes.com is the source for this information.


14 August, 2020

ICICI Securities recommends buying Aster DM Healthcare with a target price of Rs 166.

Aster DM Healthcare has been assigned a buy recommendation by ICICI Securities, with a target price of Rs 166. From its previous finish of Rs 134.75, the stock dropped 2.72 percent. The latest trading price of the stock was Rs 131.35.

Aster DM Healthcare Ltd., founded in 2008, is a Mid Worth business in the Hospitals & Allied Services category with a market cap of Rs 6633.53 crore.

Financials For the quarter ended June 30, 2020, the firm reported consolidated sales of Rs 1760.63 crore, a decrease of 23.50 percent from the previous quarter’s sales of Rs 2301.37 crore and a decrease of 13.21 percent from the same period last year’s sales of Rs 2028.59 crore. In the most recent quarter, the company posted a net profit after tax of Rs -89.61 crore.

Reasons for Investing

To account for the partially sustainable cost management actions, the brokerage has lifted profit projections for FY21E/FY22E by 2.2/5.9%. At 6.6xFY22E EV/EBITDA, the stock is a good buy. It keeps the stock as BUY, with a revised SoTP-based target price of Rs166/share.

The following are the call’s main negative risks:

Regulatory roadblocks, a larger-than-expected impact of CVOID-19, and a longer-than-expected turnaround time for new facilities.

FII Holdings/Promoter

As of June 30, 2020, promoters owned 37.9% of the firm, while FIIs held 8.8%, DIIs 10.1 percent, and public and others 43.2 percent.

economictimes.com is the source for this information.


09 January, 2020

Aster DM Healthcare would buy back 120 crore worth of shares.

In Thursday’s trading, Aster DM Healthcare’s stock jumped more than 7% after the board authorised a proposal to buy back shares worth up to Rs 120 crore.

According to the regulatory filing, the corporation would buy back up to 1.13 percent of its stock at Rs 210 per share.

“Members of the company’s promoter and promoter group have expressed an interest in participating in the buyback.” “The board has set January 24 as the record date for assessing entitlement and the names of shareholders who are eligible to participate in the repurchase,” Aster DM added.

As of December 31, the company’s promoters owned 37.80% of the stock. The corporation was owned 51.40 percent by foreign investors and 4.94 percent by domestic financial institutions.

On the BSE, the stock finished 2.59 percent higher at Rs 164.40.

economictimes.com is the source for this information.


Disclaimer: The views and investment tips expressed by investment expert on Stock consultant bihar are Sourced From Brokerage Firms Research Reports & Market Experts Opinion. We advises users to consult your investment advisor before taking any decisions. Our Website Contain Demat Account & Algo Trading affliate Link. If You’ll Register Through Our Link We May Get Profit.

More Share Price Target Updates:

We will be happy to hear your thoughts

Leave a reply

Stock Consultant Bihar
Logo